Company intelligence / Profile preview

Medvac BioPharma

Hyderabad, Telangana, India

Ownership: Private
Development stage: Other

Overview

Medvac BioPharma is an Indian biopharmaceutical company headquartered in Hyderabad, specializing in the research, development, and manufacturing of affordable vaccines and biologics. The company focuses on addressing infectious diseases through its robust vaccine pipeline, which includes candidates for COVID-19, Rabies, Hepatitis B, and Typhoid. Medvac utilizes advanced cell-culture and recombinant DNA technologies to produce high-quality immunizations for global markets. With a mission to enhance public health accessibility, the firm is actively expanding its manufacturing capabilities to meet the growing demand for essential vaccines in emerging economies.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologicRecombinant protein
Industry: Biotech

Beyond the preview

Go deeper on Medvac BioPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medvac BioPharma.

Explore the full profile